483
Novartis Pharmaceuticals CorporationNovartis Pharmaceuticals Corporation – FDA 483, Jan 24, 2017
Record Details
Novartis Pharmaceuticals Corp. in East Hanover, NJ, was cited for significant deficiencies in its conduct as a sponsor of clinical investigations. Observations included failures to notify the FDA of an investigator's termination, retain required records, adequately monitor study progress, and ensure studies adhered to protocols and investigational plans. These issues indicate systemic problems in clinical trial oversight.
View Company Profile
ID · 4337d8c5-ec9f-4ec5-9878-9d9925dbaf1b
Other documents for Novartis Pharmaceuticals Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.